AUG 17, 2026 · PHASE 2 TRIAL
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
ClinicalTrials.gov
This is a Phase 2 trial registration with no reported results; the study is actively recruiting and outcome data are not yet available.
Reported
Planned enrollment360
Primary outcome measureChange from Baseline to Day 42 in Hamilton…
Study phasePhase 2